Skip to main content
Erschienen in: World Journal of Urology 2/2004

01.06.2004 | Free Paper

Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP

verfasst von: Bernhard Planz, Horia Oltean, Thomas Deix, Sandra D. Kirley, Qi Fa Wang, W. S. McDougal, Michael Marberger

Erschienen in: World Journal of Urology | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Keratinocyte growth factor (KGF) has paracrine properties in the human prostate which stimulate epithelial cell growth. Activins have profound effects on cell growth and function in the human prostate, and are expressed in LNCaP, DU 145 and PC3 cells. LNCaP cells were characterized by immuncytochemistry, an immunoassay and polymerase chain reaction. A 3[H]thymidine assay was used with 0.01–10 nM dihydrotestosterone, 10 µM flutamide, 1–100 ng/ml KGF and 3 nM activin. LNCaP cells expressed Ki67, PSA, cytokeratins (8, 18, 19, 14, 15) androgenreceptor but no KGF protein. LNCaP cells showed telomerase activity. Furthermore, ARmRNA (365 bp), but no KGF or KGFRmRNA were expressed. KGF ELISA detected no intracellular or secreted KGF. DHT (1, 10 and 100 nM) and KGF (10 and 100 ng/ml) significantly stimulated LNCaP cell proliferation. However, flutamide and 3 nM activin A significantly decreased cell proliferation in the presence and absence of KGF. The results of our experiments support the hypothesis that cell growth and proliferative characteristics of LNCaP cells are modulated by KGF and activin A.
Literatur
1.
Zurück zum Zitat Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Cancer Res 54:5474–5478PubMed Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Cancer Res 54:5474–5478PubMed
2.
Zurück zum Zitat Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H (1995) Activation of the androgen receptor by polypeptide growth factors and cellular regulators. World J Urol 13: 285–289PubMed Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H (1995) Activation of the androgen receptor by polypeptide growth factors and cellular regulators. World J Urol 13: 285–289PubMed
3.
Zurück zum Zitat Dahiya R, Lee C, Haughney PC, Chui HR, Deng G (1996) Differential gene expression of transforming growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines. Urology 48: 963–970 Dahiya R, Lee C, Haughney PC, Chui HR, Deng G (1996) Differential gene expression of transforming growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines. Urology 48: 963–970
4.
Zurück zum Zitat De Paulo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N (1991) Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 198:500–512PubMed De Paulo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N (1991) Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 198:500–512PubMed
5.
Zurück zum Zitat Di Loreto C, Reis FM, Cataldi P, Zuiani C, Luisi S, Beltrami CA, Petraglia F (1999) Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid. Eur J Endocrinol 141:190–194 Di Loreto C, Reis FM, Cataldi P, Zuiani C, Luisi S, Beltrami CA, Petraglia F (1999) Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid. Eur J Endocrinol 141:190–194
6.
Zurück zum Zitat Fasciana C, Van der Made AC, Faber PW, Trapman J (1996) Androgen regulation of the rat keratinocyte growth actor (KGF/FGF7) promoter. Biochem Biophys Res Commun 220: 858–863CrossRefPubMed Fasciana C, Van der Made AC, Faber PW, Trapman J (1996) Androgen regulation of the rat keratinocyte growth actor (KGF/FGF7) promoter. Biochem Biophys Res Commun 220: 858–863CrossRefPubMed
7.
Zurück zum Zitat Finch PW, Rubin JS, Miki T et al. (1989) Human KGF is FGF related with properties of a paracrine effector of epithelial cell growth. Science 245:752PubMed Finch PW, Rubin JS, Miki T et al. (1989) Human KGF is FGF related with properties of a paracrine effector of epithelial cell growth. Science 245:752PubMed
8.
Zurück zum Zitat Horoszewicz JS, Leong SS, Kawinski E, Karr J, Rosenthal H, Chu TM, Mirand EA, Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43:1809–1818PubMed Horoszewicz JS, Leong SS, Kawinski E, Karr J, Rosenthal H, Chu TM, Mirand EA, Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43:1809–1818PubMed
9.
Zurück zum Zitat Ittman M, Mansukhani A (1997) Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 157:351CrossRefPubMed Ittman M, Mansukhani A (1997) Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 157:351CrossRefPubMed
10.
Zurück zum Zitat Kuratsukuri K, Sugimura K, Harimoto K, Kawashima H, Kishimoto T (1999) “Decoy” of androgen-responsive element induces apoptosis in LNCaP cells. Prostate 41: 121–126CrossRefPubMed Kuratsukuri K, Sugimura K, Harimoto K, Kawashima H, Kishimoto T (1999) “Decoy” of androgen-responsive element induces apoptosis in LNCaP cells. Prostate 41: 121–126CrossRefPubMed
11.
Zurück zum Zitat Leung HY, Mehta P, Gray LB et al. (1997) Keratinocyte growth factor expression in hormone insensitive prostate cancer. Oncogene 15:1115CrossRefPubMed Leung HY, Mehta P, Gray LB et al. (1997) Keratinocyte growth factor expression in hormone insensitive prostate cancer. Oncogene 15:1115CrossRefPubMed
12.
Zurück zum Zitat Lin MF, Lee MS, Garcia-Arenas R, Lin FF (2000) Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells. Cell Biol Int 24: 681–689CrossRefPubMed Lin MF, Lee MS, Garcia-Arenas R, Lin FF (2000) Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells. Cell Biol Int 24: 681–689CrossRefPubMed
13.
Zurück zum Zitat Nishihara T, Okahashi N, Ueda N (1993) Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985–991CrossRefPubMed Nishihara T, Okahashi N, Ueda N (1993) Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985–991CrossRefPubMed
14.
Zurück zum Zitat Planz B, Wang QF, Kirley SD et al. (1998) Androgen responsiveness of stromal cells of the human prostate: regulation of cell proliferation and keratinocyte growth factor by androgen. J Urol 160:1850CrossRefPubMed Planz B, Wang QF, Kirley SD et al. (1998) Androgen responsiveness of stromal cells of the human prostate: regulation of cell proliferation and keratinocyte growth factor by androgen. J Urol 160:1850CrossRefPubMed
15.
Zurück zum Zitat Planz B, Aretz HT, Wang QF, Tabatabaei S, Kirley SD et al. (1999) Immunolocalisation of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 41:233–242CrossRefPubMed Planz B, Aretz HT, Wang QF, Tabatabaei S, Kirley SD et al. (1999) Immunolocalisation of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 41:233–242CrossRefPubMed
16.
Zurück zum Zitat Rubin JS, Osada H, Finch PW et al. (1989) Purification and characterization of newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A 86:802PubMed Rubin JS, Osada H, Finch PW et al. (1989) Purification and characterization of newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A 86:802PubMed
17.
Zurück zum Zitat Sanger F, Nicklen S, Coulson AR (1977) DNA-sequencing with chain terminating inhibitors. Proc Natl Acad Sci U S A 74:5463PubMed Sanger F, Nicklen S, Coulson AR (1977) DNA-sequencing with chain terminating inhibitors. Proc Natl Acad Sci U S A 74:5463PubMed
18.
Zurück zum Zitat Taplin ME, Bubley GJ, Shuster TD et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393 Taplin ME, Bubley GJ, Shuster TD et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393
19.
Zurück zum Zitat Thomas TZ, Wang H, Niclasen P, O’Bryan MK, Evans LW, Groome NP, Pedersen J, Risibridger GP (1997) Expression and localisation of activin subunits and follistatins in tissues from men with high grade prostate cancer. J Clin Endocrinol Metab 82:3851–1858PubMed Thomas TZ, Wang H, Niclasen P, O’Bryan MK, Evans LW, Groome NP, Pedersen J, Risibridger GP (1997) Expression and localisation of activin subunits and follistatins in tissues from men with high grade prostate cancer. J Clin Endocrinol Metab 82:3851–1858PubMed
20.
Zurück zum Zitat Wang QF, Tabatabaei S, Planz B, Lin CW, Sluss PM (1999) Identification of an activin-folistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells. J Urol 161:1378–1384PubMed Wang QF, Tabatabaei S, Planz B, Lin CW, Sluss PM (1999) Identification of an activin-folistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells. J Urol 161:1378–1384PubMed
Metadaten
Titel
Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP
verfasst von
Bernhard Planz
Horia Oltean
Thomas Deix
Sandra D. Kirley
Qi Fa Wang
W. S. McDougal
Michael Marberger
Publikationsdatum
01.06.2004
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 2/2004
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-003-0391-7

Weitere Artikel der Ausgabe 2/2004

World Journal of Urology 2/2004 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.